123 related articles for article (PubMed ID: 8964850)
1. Aging and renal responsiveness to parathyroid hormone in healthy men.
Halloran BP; Lonergan ET; Portale AA
J Clin Endocrinol Metab; 1996 Jun; 81(6):2192-7. PubMed ID: 8964850
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
3. Influence of vitamin D on parathyroid function in the elderly.
Quesada JM; Coopmans W; Ruiz B; Aljama P; Jans I; Bouillon R
J Clin Endocrinol Metab; 1992 Aug; 75(2):494-501. PubMed ID: 1639950
[TBL] [Abstract][Full Text] [Related]
4. Aging alters calcium regulation of serum concentration of parathyroid hormone in healthy men.
Portale AA; Lonergan ET; Tanney DM; Halloran BP
Am J Physiol; 1997 Jan; 272(1 Pt 1):E139-46. PubMed ID: 9038863
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man.
Fraher LJ; Hodsman AB; Jonas K; Saunders D; Rose CI; Henderson JE; Hendy GN; Goltzman D
J Clin Endocrinol Metab; 1992 Aug; 75(2):417-23. PubMed ID: 1322424
[TBL] [Abstract][Full Text] [Related]
6. Alterations in calcium, vitamin D, and parathyroid hormone physiology in normal men with aging: relationship to the development of senile osteopenia.
Orwoll ES; Meier DE
J Clin Endocrinol Metab; 1986 Dec; 63(6):1262-9. PubMed ID: 3023418
[TBL] [Abstract][Full Text] [Related]
7. Age-related changes in serum immunoreactive parathyroid hormone and its biological action in healthy men and women.
Endres DB; Morgan CH; Garry PJ; Omdahl JL
J Clin Endocrinol Metab; 1987 Oct; 65(4):724-31. PubMed ID: 2821053
[TBL] [Abstract][Full Text] [Related]
8. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.
Law WM; Heath H
J Clin Invest; 1983 Sep; 72(3):1106-13. PubMed ID: 6309905
[TBL] [Abstract][Full Text] [Related]
9. Comparison of renal responses to synthetic human PTH(1-34) administration in normal young and elderly male subjects.
Imanaka S; Onishi T; Morimoto S; Takamoto S; Kohno H; Kumahara Y
Calcif Tissue Int; 1985 Jul; 37(4):357-62. PubMed ID: 2994859
[TBL] [Abstract][Full Text] [Related]
10. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
Aksnes L; Aarskog D
J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
[TBL] [Abstract][Full Text] [Related]
11. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
[TBL] [Abstract][Full Text] [Related]
12. Effect of aging on the metabolism of phosphorus and 1,25-dihydroxyvitamin D in healthy men.
Portale AA; Halloran BP; Morris RC; Lonergan ET
Am J Physiol; 1996 Mar; 270(3 Pt 1):E483-90. PubMed ID: 8638697
[TBL] [Abstract][Full Text] [Related]
13. A 6-hour human parathyroid hormone (1-34) infusion protocol: studies in normal and hypoparathyroid subjects.
McElduff A; Lissner D; Wilkinson M; Cornish C; Posen S
Calcif Tissue Int; 1987 Nov; 41(5):267-73. PubMed ID: 2825934
[TBL] [Abstract][Full Text] [Related]
14. Calcium potentiates the cyclic nucleotide and phosphaturic response to parathyroid hormone infusion.
Bikle DD; Herman RH
J Clin Endocrinol Metab; 1983 Jan; 56(1):11-7. PubMed ID: 6292254
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3.
Ledger GA; Burritt MF; Kao PC; O'Fallon WM; Riggs BL; Khosla S
J Clin Endocrinol Metab; 1994 Jul; 79(1):211-6. PubMed ID: 8027229
[TBL] [Abstract][Full Text] [Related]
16. Effect of parathyroid hormone (hPTH[1-34]) infusion on serum 1,25-dihydroxyvitamin D and parathyroid hormone in normal women.
Kinyamu HK; Gallagher JC; Petranick KM; Ryschon KL
J Bone Miner Res; 1996 Oct; 11(10):1400-5. PubMed ID: 8889838
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans.
Fraher LJ; Klein K; Marier R; Freeman D; Hendy GN; Goltzman D; Hodsman AB
J Clin Endocrinol Metab; 1995 Jan; 80(1):60-4. PubMed ID: 7829640
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone does not increase nephrogenous cyclic AMP excretion by the dog.
Fox J; Heath H
Endocrinology; 1980 Dec; 107(6):2124-5. PubMed ID: 6253291
[TBL] [Abstract][Full Text] [Related]
19. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
[TBL] [Abstract][Full Text] [Related]
20. Selective modulation by vitamin D of renal response to parathyroid hormone: a study in calcitriol-resistant rickets.
Even L; Weisman Y; Goldray D; Hochberg Z
J Clin Endocrinol Metab; 1996 Aug; 81(8):2836-40. PubMed ID: 8768839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
